Split History
ETFs Holding MELA »    MELA Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
MELA Sciences is a medical device company engaged in the designing and developing software-driven technology for the detection of skin cancer. Co.'s primary product, the MelaFind® System (MelaFind), is non-invasive, point-of-care instrument to aid in the detection of melanoma. The System features a hand-held component that emits light of multiple wavelengths to capture digital data from clinically atypical pigmented skin lesions. The components include: a hand-held imager, which employs optics and multi-spectral illumination; proprietary database of pigmented skin lesions; and lesion classifiers, which are mathematical algorithms that extract lesion feature information and classify lesions. According to our MELA split history records, MELA has had 1 split.
MELA split history picture
MELA (MELA) has 1 split in our MELA split history database. The split for MELA took place on July 10, 2014. This was a 1 for 10 reverse split, meaning for each 10 shares of MELA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as MELA conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the MELA split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into MELA shares, starting with a $10,000 purchase of MELA, presented on a split-history-adjusted basis factoring in the complete MELA split history. MELA split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/16/2009
End date: 01/04/2016
Start price/share: $88.90
End price/share: $1.12
Dividends collected/share: $0.00
Total return: -98.74%
Average Annual Total Return: -50.97%
Starting investment: $10,000.00
Ending investment: $126.00
Years: 6.14
Date Ratio
07/10/20141 for 10
MELA is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

MGEN Split History
MLNT Split History
MMM Split History
MMSI Split History
MNKD Split History
MOH Split History
MR Split History
MRK Split History
MSON Split History
MTEM Split History

TRACON Pharmaceuticals (TCON)
SELLAS Life Sciences Group, Inc. (SLS)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Camber Energy, Inc. (CEI)
Cancer Genetics, Inc. (CGIX)
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3X Shares (GUSH)
Kingold Jewelry, Inc. (KGJI)
Aethlon Medical, Inc. (AEMD)
Aberdeen Standard Physical Gold Shares ETF (SGOL)
Safe-T Group Ltd. (SFET)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

MELA Insider Buying

MELA Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.